This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cigna Volunteer Of The Year Brian Urban (right) With His Dad Jim Urban. Jim Died Of Prostate Cancer, Which Is One Reason Brian Works To Fight The Disease. (Photo: Cigna Corporation)

Brian Urban, a health educator and case management specialist from Baldwin, Penn., has been named Cigna's (NYSE: CI) Volunteer of the Year for his work with the Obediah Cole Prostate Cancer Foundation in Pittsburgh, Penn.
Cigna Volunteer of the year Brian Urban (right) with his dad Jim Urban. Jim died of prostate cancer, ...

Cigna Volunteer of the year Brian Urban (right) with his dad Jim Urban. Jim died of prostate cancer, which is one reason Brian works to fight the disease. (Photo: Cigna Corporation)

Obediah Cole provides free prostate cancer screenings and promotes early detection, education, awareness and support for those with the disease. It also promotes healthy living, nutrition, and exercise.

Urban’s passion for the cause is rooted in the tragic loss of his father to prostate cancer in 2005, when his dad was just 55 years old. Brian Urban was 19 years old at the time.

“My dad was so young when he died, and his death could have been prevented. Through my work with Obediah Cole promoting early detection and prevention, I honor his legacy by helping others avoid losing their loved ones,” Urban said. “I’m grateful to Cigna for encouraging the spirit of volunteerism and supporting me in my efforts with the Cole Foundation.”

Urban, who serves as the organization’s Health Promotion Coordinator, was singled out for both his creative leadership and his effectiveness in bringing awareness and prostate health services to a wide variety of people within the Pittsburgh community.

“Brian’s valuable contributions to Obediah Cole help us offer free prostate cancer screenings to thousands of men,” said Jerry Livingston, vice president of Obediah Cole Prostate Cancer Foundation. “His contributions, energy, and ideas are critical to the success we have had. To me Brian is the future leadership of the organization.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.64 -0.11%
FB $118.57 0.84%
GOOG $698.21 0.75%
TSLA $241.80 0.43%
YHOO $36.53 -0.19%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs